A Phase 1 Study To Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function

Plazomicin is an FDA-approved aminoglycoside for the treatment of complicated urinary tract infections. In this open-label study, 24 adults with normal renal function or mild, moderate, or severe renal impairment (n = 6 per group) received a single 7.5-mg/kg of body weight dose of plazomicin as a 30...

Descripción completa

Detalles Bibliográficos
Autores principales: Komirenko, Allison S., Riddle, Valerie, Gibbons, Jacqueline A., Van Wart, Scott, Seroogy, Julie D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256775/
https://www.ncbi.nlm.nih.gov/pubmed/30275092
http://dx.doi.org/10.1128/AAC.01128-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256775/
https://www.ncbi.nlm.nih.gov/pubmed/30275092
http://dx.doi.org/10.1128/AAC.01128-18

Ejemplares similares